TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study.
In cancer patients, plasma often contains mutant DNA released by cancer cells. We have assessed the significance of plasma DNA mutations for subsequent cancer development in healthy subjects in a large longitudinal prospective study. The European Prospective Investigation into Cancer and Nutrition s...
主要な著者: | Gormally, E, Vineis, P, Matullo, G, Veglia, F, Caboux, E, Le Roux, E, Peluso, M, Garte, S, Guarrera, S, Munnia, A, Airoldi, L, Autrup, H, Malaveille, C, Dunning, A, Overvad, K, Tjønneland, A, Lund, E, Clavel-Chapelon, F, Boeing, H, Trichopoulou, A, Palli, D, Krogh, V, Tumino, R, Panico, S, Bueno-de-Mesquita, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2006
|
類似資料
-
TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: A prospective study
著者:: Gormally, E, 等
出版事項: (2006) -
Amount of DNA in plasma and cancer risk: a prospective study.
著者:: Gormally, E, 等
出版事項: (2004) -
Amount of DNA in plasma and cancer risk: A prospective study
著者:: Gormally, E, 等
出版事項: (2004) -
DNA adducts and lung cancer risk: A prospective study
著者:: Peluso, M, 等
出版事項: (2005) -
DNA adducts and lung cancer risk: a prospective study.
著者:: Peluso, M, 等
出版事項: (2005)